Human Breast Milk-Derived Antibodies Protect Against Influenza and Show Broad Antiviral Activity

Published in Science Advances, the preclinical research demonstrates the potential of a nasal antibody treatment being developed by Lactiga to help protect patients with compromised immune systems against life-threatening respiratory infections. NORTH BRUNSWICK, N.J., Oct. 29, 2026...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.